This study aimed to address this research gap by focusing on the leucine-rich repeat neuronal (LRRN) family, with the goal of clarifying their expression, clinical value, and prognostic significance in breast cancer—particularly LRRN1 in advanced cases. This evidence concerns the gene LRRN1 and breast carcinoma.